178 related articles for article (PubMed ID: 7797587)
1. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin.
Pemberton PA; Wong DT; Gibson HL; Kiefer MC; Fitzpatrick PA; Sager R; Barr PJ
J Biol Chem; 1995 Jun; 270(26):15832-7. PubMed ID: 7797587
[TBL] [Abstract][Full Text] [Related]
2. Functional implications of the modeled structure of maspin.
Fitzpatrick PA; Wong DT; Barr PJ; Pemberton PA
Protein Eng; 1996 Jul; 9(7):585-9. PubMed ID: 8844830
[TBL] [Abstract][Full Text] [Related]
3. Maspin inhibits cell migration in the absence of protease inhibitory activity.
Bass R; Fernández AM; Ellis V
J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
[TBL] [Abstract][Full Text] [Related]
4. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
5. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
Sheng S; Truong B; Fredrickson D; Wu R; Pardee AB; Sager R
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):499-504. PubMed ID: 9435220
[TBL] [Abstract][Full Text] [Related]
6. Production, purification, and characterization of recombinant maspin proteins.
Sheng S; Pemberton PA; Sager R
J Biol Chem; 1994 Dec; 269(49):30988-93. PubMed ID: 7983035
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained.
Al-Ayyoubi M; Gettins PG; Volz K
J Biol Chem; 2004 Dec; 279(53):55540-4. PubMed ID: 15501821
[TBL] [Abstract][Full Text] [Related]
8. Maspin. A tumor suppressing serpin.
Sager R; Sheng S; Pemberton P; Hendrix MJ
Adv Exp Med Biol; 1997; 425():77-88. PubMed ID: 9433491
[TBL] [Abstract][Full Text] [Related]
9. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge.
Sheng S
J Cell Physiol; 2006 Dec; 209(3):631-5. PubMed ID: 17001674
[TBL] [Abstract][Full Text] [Related]
10. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule.
Ngamkitidechakul C; Warejcka DJ; Burke JM; O'Brien WJ; Twining SS
J Biol Chem; 2003 Aug; 278(34):31796-806. PubMed ID: 12799381
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop.
Becerra SP; Sagasti A; Spinella P; Notario V
J Biol Chem; 1995 Oct; 270(43):25992-9. PubMed ID: 7592790
[TBL] [Abstract][Full Text] [Related]
12. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.
Zhang M; Sheng S; Maass N; Sager R
Mol Med; 1997 Jan; 3(1):49-59. PubMed ID: 9132279
[TBL] [Abstract][Full Text] [Related]
13. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen.
Blacque OE; Worrall DM
J Biol Chem; 2002 Mar; 277(13):10783-8. PubMed ID: 11788595
[TBL] [Abstract][Full Text] [Related]
15. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions.
Al-Ayyoubi M; Schwartz BS; Gettins PG
J Biol Chem; 2007 Jul; 282(27):19502-9. PubMed ID: 17510061
[TBL] [Abstract][Full Text] [Related]
16. SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases.
Askew YS; Pak SC; Luke CJ; Askew DJ; Cataltepe S; Mills DR; Kato H; Lehoczky J; Dewar K; Birren B; Silverman GA
J Biol Chem; 2001 Dec; 276(52):49320-30. PubMed ID: 11604408
[TBL] [Abstract][Full Text] [Related]
17. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
Biliran H; Sheng S
Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells.
Odero-Marah VA; Khalkhali-Ellis Z; Schneider GB; Seftor EA; Seftor RE; Koland JG; Hendrix MJ
Biochem Biophys Res Commun; 2002 Jul; 295(4):800-5. PubMed ID: 12127964
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive maspin and epithelial homeostasis.
Lockett J; Yin S; Li X; Meng Y; Sheng S
J Cell Biochem; 2006 Mar; 97(4):651-60. PubMed ID: 16329135
[TBL] [Abstract][Full Text] [Related]
20. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
Sheng S; Carey J; Seftor EA; Dias L; Hendrix MJ; Sager R
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11669-74. PubMed ID: 8876194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
